Komipharm International Co (XKRX:041960) Other Net Income (Loss) : ₩0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Other Net Income (Loss)?

Komipharm International Co's Other Net Income (Loss) for the three months ended in Dec. 2024 was ₩-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

Komipharm International Co's quarterly Other Net Income (Loss) increased from Jun. 2024 (₩0 Mil) to Sep. 2024 (₩0 Mil) but then declined from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩-0 Mil).

Komipharm International Co's annual Other Net Income (Loss) declined from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩-0 Mil) but then increased from Dec. 2023 (₩-0 Mil) to Dec. 2024 (₩0 Mil).

Komipharm International Co Other Net Income (Loss) Historical Data

The historical data trend for Komipharm International Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Other Net Income (Loss) Chart

Komipharm International Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Komipharm International Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-171.15	-	-	-	-

Komipharm International Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

Komipharm International Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Komipharm International Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Komipharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450

Website

http://www.komilab.co.kr

Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines